| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | ARIAD PHARMACEUTICALS INC | 12,000,000 | 96,720,000 | 33.30% | ||
| 2 | QUEST DIAGNOSTICS INC | 775,000 | 44,888,000 | 15.46% | ||
| 3 | BIO-REFERENCE LABS INC | 1,280,984 | 35,458,000 | 12.21% | ||
| 4 | Idenix Pharmaceuticals Inc | 5,050,100 | 30,452,000 | 10.49% | ||
| 5 | MERCK & CO INC | 400,000 | 22,708,000 | 7.82% | ||
| 6 | MALLINCKRODT PUB LTD CO SHS | 274,895 | 17,431,000 | 6.00% | ||
| 7 | VIVUS INC | 2,573,943 | 15,289,000 | 5.26% | ||
| 8 | REPROS THERAPEUTICS INC | 560,600 | 9,945,000 | 3.42% | ||
| 9 | AVEO PHARMACEUTICALS INC | 2,570,759 | 3,843,000 | 1.32% | ||
| 10 | LABORATORY CORP AMER HLDGS | 37,824 | 3,715,000 | 1.28% | ||
| 11 | INTRA CELLULAR THERAPIES INC COM | 126,695 | 2,303,000 | 0.79% | ||
| 12 | ONCONOVA THERAPEUTICS | 350,000 | 2,219,000 | 0.76% | ||
| 13 | ENANTA PHARMACEUTICALS INC COM | 50,000 | 2,000,000 | 0.69% | ||
| 14 | KINDRED BIOSCIENCES INC | 101,825 | 1,887,000 | 0.65% | ||
| 15 | TARGACEPT INC | 329,516 | 1,565,000 | 0.54% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001140361-14-021259, filed 2014.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
